Franklin Biotechnology Discovery Fund Quote
| FTDZX Fund | USD 136.70 0.79 0.57% |
Performance2 of 100
| Odds Of DistressLess than 22
|
Franklin Biotechnology is trading at 136.70 as of the 18th of April 2024; that is -0.57 percent decrease since the beginning of the trading day. The fund's open price was 137.49. Franklin Biotechnology has about a 22 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Franklin Biotechnology Discovery are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 19th of January 2024 and ending today, the 18th of April 2024. Click here to learn more.
Under normal market conditions, the fund invests at least 80 percent of its net assets in securities of biotechnology companies and discovery research firms. The fund predominantly invests in equity securities. In addition to its investments in biotechnology companies, the fund may also invest up to 20 percent of its net assets in equity or debt securities of any type of issuer. More on Franklin Biotechnology Discovery
Moving together with Franklin Mutual Fund
| 0.64 | TEDMX | Templeton Developing | PairCorr |
Franklin Mutual Fund Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Franklin Biotechnology's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Franklin Biotechnology or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Fund Concentration | Franklin Templeton Investments Funds, Large Funds, Health Funds, Health, Franklin Templeton Investments, Large, Health (View all Sectors) |
| Update Date | 31st of March 2024 |
Franklin Biotechnology Discovery [FTDZX] is traded in USA and was established 18th of April 2024. Franklin Biotechnology is listed under Franklin Templeton Investments category by Fama And French industry classification. The fund is listed under Health category and is part of Franklin Templeton Investments family. This fund currently has accumulated 1.42 B in assets under management (AUM) with minimum initial investment of 100 K. Franklin Biotechnology is currently producing year-to-date (YTD) return of 5.89%, while the total return for the last 3 years was -0.06%.
Check Franklin Biotechnology Probability Of Bankruptcy
Instrument Allocation
Sector Allocation
Investors will always prefer to have their portfolios divercified against different sectors. The broad sector allocation increases the possibility of making a profit or at least avoiding a loss. However, this may also reduce the expected return on Franklin Mutual Fund. Generally, it depends on diversification level and type but usually, the broader the sector allocation, the less risk can be expected from holding Franklin Mutual Fund, and the less return is expected.
Institutional investors that are interested in enforcing a sector tilt in their portfolio can use exchange-traded funds, such as Franklin Biotechnology Discovery Mutual Fund, as a low-cost alternative to building a custom portfolio. So, using sector ETFs to diversify your portfolio can be a profitable strategy. However, no matter what sectors are desirable at a given time, no single industry should ever make up more than 20 percent of your stock portfolio.
Top Franklin Biotechnology Discovery Mutual Fund Constituents
| CLVS | Clovis Oncology | Stock | Health Care |
| NBIX | Neurocrine Biosciences | Stock | Health Care |
| VRTX | Vertex Pharmaceuticals | Stock | Health Care |
| SGEN | Seagen Inc | Stock | Health Care |
| RETA | Reata Pharmaceuticals | Stock | Health Care |
| REGN | Regeneron Pharmaceuticals | Stock | Health Care |
| PTCT | PTC Therapeutics | Stock | Health Care |
Franklin Biotechnology Target Price Odds Analysis
Based on a normal probability distribution, the odds of Franklin Biotechnology jumping above the current price in 90 days from now is about 92.2%. The Franklin Biotechnology Discovery probability density function shows the probability of Franklin Biotechnology mutual fund to fall within a particular range of prices over 90 days. Assuming the 90 days horizon the mutual fund has a beta coefficient of 1.3397. This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Franklin Biotechnology will likely underperform. Additionally, franklin Biotechnology Discovery has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Franklin Biotechnology to move above the current price in 90 days from now is about 92.2 (This Franklin Biotechnology Discovery probability density function shows the probability of Franklin Mutual Fund to fall within a particular range of prices over 90 days) .
Franklin Biotechnology Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Franklin Biotechnology market risk premium is the additional return an investor will receive from holding Franklin Biotechnology long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Franklin Biotechnology. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Franklin Biotechnology's alpha and beta are two of the key measurements used to evaluate Franklin Biotechnology's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.01 | |||
| Semi Deviation | 1.22 | |||
| Standard Deviation | 1.22 | |||
| Variance | 1.48 |
Franklin Biotechnology Against Markets
Picking the right benchmark for Franklin Biotechnology mutual fund is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Franklin Biotechnology mutual fund price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Franklin Biotechnology is critical whether you are bullish or bearish towards Franklin Biotechnology Discovery at a given time. Please also check how Franklin Biotechnology's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Franklin Biotechnology without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Anywhere Now
Portfolio AnywhereTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
How to buy Franklin Mutual Fund?
Before investing in Franklin Biotechnology, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Franklin Biotechnology. To buy Franklin Biotechnology fund, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Franklin Biotechnology. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Franklin Biotechnology fund. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Franklin Biotechnology Discovery fund in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Franklin Biotechnology Discovery fund, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the fund
It's important to note that investing in stocks, such as Franklin Biotechnology Discovery, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in fund prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Franklin Biotechnology Discovery?
The danger of trading Franklin Biotechnology Discovery is mainly related to its market volatility and Mutual Fund specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Franklin Biotechnology is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Franklin Biotechnology. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Franklin Biotechnology is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Franklin Biotechnology Discovery. Also, note that the market value of any mutual fund could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Franklin Biotechnology information on this page should be used as a complementary analysis to other Franklin Biotechnology's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.